Germline genomic testing to assess the suitability of stem cell donors in the treatment of haematological malignancy: clinical ethics commentary.

Carley H, Sahan K, Hanson H, Snape K, Westbury S, Parker MJ, Lucassen AM

Open source

DOI
10.1136/jme-2025-111111
Published
2026 Sep 22
Container
Journal of medical ethics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jme-2025-111111,
  title = {Germline genomic testing to assess the suitability of stem cell donors in the treatment of haematological malignancy: clinical ethics commentary.},
  author = {Carley H and Sahan K and Hanson H and Snape K and Westbury S and Parker MJ and Lucassen AM},
  year = {2026},
  journal = {Journal of medical ethics},
  doi = {10.1136/jme-2025-111111},
  url = {https://doi.org/10.1136/jme-2025-111111}
}

RIS

TY  - JOUR
TI  - Germline genomic testing to assess the suitability of stem cell donors in the treatment of haematological malignancy: clinical ethics commentary.
AU  - Carley H
AU  - Sahan K
AU  - Hanson H
AU  - Snape K
AU  - Westbury S
AU  - Parker MJ
AU  - Lucassen AM
PY  - 2026
JO  - Journal of medical ethics
DO  - 10.1136/jme-2025-111111
UR  - https://doi.org/10.1136/jme-2025-111111
ER  - 

APA

H, C., K, S., H, H., K, S., S, W., MJ, P., & AM, L. (2026). Germline genomic testing to assess the suitability of stem cell donors in the treatment of haematological malignancy: clinical ethics commentary.. Journal of medical ethics. https://doi.org/10.1136/jme-2025-111111

Source records